DA
HQL

Doliver Advisors’s abrdn Life Sciences Investors HQL Stock Holding History

Doliver Advisors’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12,136
Closed -$212K – 187
2020
Q1 		$212K Sell
12,136
-14,734
-55% -$241K 0.1% 111
2019
Q4 		$468K Buy
26,870
+10,048
+60% +$165K 0.19% 55
2019
Q3 		$255K Buy
+16,822
New +$269K 0.1% 88
2018
Q3 		– Sell
-33,626
Closed -$632K – 242
2018
Q2 		$632K Buy
33,626
+18,990
+130% +$357K 0.26% 58
2018
Q1 		$281K Sell
14,636
-3,186
-18% -$63.8K 0.12% 158
2017
Q4 		$350K Buy
+17,822
New +$357K 0.14% 123
2017
Q1 		– Sell
-25,493
Closed -$433K – 253
2016
Q4 		$433K Sell
25,493
-32,648
-56% -$573K 0.37% 92
2016
Q3 		$1.09M Buy
58,141
+26,063
+81% +$491K 0.92% 38
2016
Q2 		$565K Sell
32,078
-61,972
-66% -$1.14M 0.48% 68
2016
Q1 		$1.69M Buy
94,050
+53,486
+132% +$971K 1.49% 20
2015
Q4 		$959K Sell
40,564
-7,899
-16% -$196K 0.76% 47
2015
Q3 		$1.09M Buy
+48,463
New +$1.36M 0.81% 40
2015
Q2 		– Sell
-50,373
Closed -$1.39M – 300
2015
Q1 		$1.39M Buy
50,373
+21,716
+76% +$592K 0.89% 23
2014
Q4 		$712K Buy
28,657
+1,961
+7% +$47.1K 0.5% 68
2014
Q3 		$590K Buy
+26,696
New +$580K 0.41% 94

Other funds holding HQL

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MC
Matisse Capital Portland, Oregon $234M AUM 19.72% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Doliver Advisors's HQL Position: Q2 2020 in Review

Doliver Advisors sold out of abrdn Life Sciences Investors (HQL) in Q2 2020, closing a stake of 12,136 shares — an estimated $212K sold.

Doliver Advisors first reported a position in HQL in Q3 2014 and held it in 15 quarters. The position peaked at $1.69M in Q1 2016. 70 funds tracked by Wall St. Rank hold HQL as of Q2 2020.

  • Doliver Advisors reported no remaining abrdn Life Sciences Investors position as of Q2 2020 after selling out during the quarter.
  • Doliver Advisors sold 12,136 abrdn Life Sciences Investors shares in Q2 2020, an estimated $212K.
  • Doliver Advisors first reported a position in abrdn Life Sciences Investors in Q3 2014 and held it in 15 quarters.
  • Doliver Advisors's abrdn Life Sciences Investors position peaked at $1.69M in Q1 2016.
  • 70 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2020.

Based on Doliver Advisors's 13F filing for Q2 2020, filed 10 Aug 2020.